RyMed Wins Catheter Row After USPTO Nixes Rival's Patent

Law360, New York (June 11, 2012, 8:19 PM EDT) -- A RyMed Technology Inc. catheter component does not infringe a patent held by rival Laboratoires Pharmaceutiques Vygon, a Tennessee federal judge ruled Thursday, following a reexamination by the U.S. Patent and Trademark Office.

The USPTO, which issued a reexamination certificate in May, invalidated all but one claim of the patent Vygon alleged the Franklin, Tenn.-based RyMed had infringed by manufacturing the component, U.S. District Judge Kevin Sharp of Tennessee federal court said. The remaining claim was not reviewed as part of the reexamination.

Vygon, which is...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.